Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Balko

Showing results (61-70 of 174) with videos related to

Pageof 18
Sort By:
International Journal of Oncology|July 7, 2009
MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasionJingchun Gao, Matthew J McConnell, Bin Yu, et al.
Pigment Cell & Melanoma Research|April 19, 2016
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrumDouglas B Johnson, Jason Roszik, Alexander N Shoushtari, et al.
NPJ Breast Cancer|July 3, 2025
Dynamic single-cell systemic immune responses in immunotherapy-treated early-stage HR+ breast cancer patientsXiaopeng Sun, Margaret L Axelrod, Adrienne G Waks, et al.
Frontiers in Immunology|December 13, 2021
Pharmacological Activation of cGAS for Cancer ImmunotherapyKyle M Garland, Jonah C Rosch, Carcia S Carson, et al.
Breast Cancer Research : BCR|September 10, 2017
ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactationMichelle M Williams, David B Vaught, Meghan Morrison Joly, et al.
Frontiers in Immunology|April 4, 2025
Molecular analysis of immune checkpoint inhibitor associated erythema nodosum-like toxicityXiaopeng Sun, Margaret L Axelrod, Paula I Gonzalez-Ericsson, et al.
Scientific Reports|March 22, 2018
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancerJhajaira M Araujo, Andrea C Gomez, Alfredo Aguilar, et al.
Molecular Cancer Research : MCR|January 1, 2017
Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL BlockadeMichelle M Williams, Linus Lee, Donna J Hicks, et al.
Nature Nanotechnology|January 22, 2019
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapyDaniel Shae, Kyle W Becker, Plamen Christov, et al.
Hematology/Oncology and Stem Cell Therapy|December 4, 2014
PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancersCarlos A Castaneda, Marco Lopez-Ilasaca, Joseph A Pinto, et al.
Pageof 18

Showing results (61-70 of 174) with videos related to

Sort By:
Pageof 18
International Journal of Oncology|July 7, 2009
MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasionJingchun Gao, Matthew J McConnell, Bin Yu, et al.
Pigment Cell & Melanoma Research|April 19, 2016
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrumDouglas B Johnson, Jason Roszik, Alexander N Shoushtari, et al.
NPJ Breast Cancer|July 3, 2025
Dynamic single-cell systemic immune responses in immunotherapy-treated early-stage HR+ breast cancer patientsXiaopeng Sun, Margaret L Axelrod, Adrienne G Waks, et al.
Frontiers in Immunology|December 13, 2021
Pharmacological Activation of cGAS for Cancer ImmunotherapyKyle M Garland, Jonah C Rosch, Carcia S Carson, et al.
Breast Cancer Research : BCR|September 10, 2017
ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactationMichelle M Williams, David B Vaught, Meghan Morrison Joly, et al.
Frontiers in Immunology|April 4, 2025
Molecular analysis of immune checkpoint inhibitor associated erythema nodosum-like toxicityXiaopeng Sun, Margaret L Axelrod, Paula I Gonzalez-Ericsson, et al.
Scientific Reports|March 22, 2018
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancerJhajaira M Araujo, Andrea C Gomez, Alfredo Aguilar, et al.
Molecular Cancer Research : MCR|January 1, 2017
Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL BlockadeMichelle M Williams, Linus Lee, Donna J Hicks, et al.
Nature Nanotechnology|January 22, 2019
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapyDaniel Shae, Kyle W Becker, Plamen Christov, et al.
Hematology/Oncology and Stem Cell Therapy|December 4, 2014
PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancersCarlos A Castaneda, Marco Lopez-Ilasaca, Joseph A Pinto, et al.
Pageof 18